Advanced Parkinson's disease presents unique end-of-life challenges that generic care planning fails to address, yet most European patients lack documented preferences for their final stages of care. This gap becomes critical as the disease progresses through severe motor dysfunction, cognitive decline, and complex medication needs that require specialized decision-making frameworks.
A cross-national analysis of 189 moderate-to-severe Parkinson's patients revealed dramatic disparities in end-of-life documentation across six European countries. German patients led with 70% having documented preferences, while Austria showed 21%, Sweden 17%, Greece 7%, Italy 3%, and Estonia recorded zero documentation. Most preferences appeared in personal advance directives rather than medical records, suggesting healthcare systems inadequately capture patient wishes.
The documentation quality proved concerning beyond the quantity differences. Most recorded preferences remained generic rather than addressing Parkinson's-specific considerations like deep brain stimulation management, medication withdrawal protocols, or swallowing difficulties that define late-stage care needs. This represents a significant oversight given Parkinson's distinct trajectory compared to other terminal conditions.
These findings expose a critical healthcare gap requiring immediate attention. Without disease-specific advance planning, families and clinicians face impossible decisions during medical crises when patients can no longer communicate. The variation suggests successful models exist in Germany that other nations could adapt. Developing Parkinson's-tailored advance directive templates and training healthcare providers in movement disorder end-of-life discussions could dramatically improve care quality and family outcomes across Europe's aging population.